GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curis Inc (NAS:CRIS) » Definitions » E10

Curis (CRIS) E10

: $-29.05 (As of Dec. 2023)
View and export this data going back to 2000. Start your Free Trial

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Curis's adjusted earnings per share data for the three months ended in Dec. 2023 was $-2.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-29.05 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -2.10% per year. During the past 5 years, the average E10 Growth Rate was -2.80% per year. During the past 10 years, the average E10 Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Curis was 37.10% per year. The lowest was -11.00% per year. And the median was -3.30% per year.

As of today (2024-04-23), Curis's current stock price is $14.85. Curis's E10 for the quarter that ended in Dec. 2023 was $-29.05. Curis's Shiller PE Ratio of today is .


Curis E10 Historical Data

The historical data trend for Curis's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.43 -27.31 -28.64 -29.14 -29.05

Curis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.14 -29.10 -29.39 -29.60 -29.05

Competitive Comparison

For the Biotechnology subindustry, Curis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curis Shiller PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Curis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Curis's Shiller PE Ratio falls into.



Curis E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Curis's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-2.03/129.4194*129.4194
=-2.030

Current CPI (Dec. 2023) = 129.4194.

Curis Quarterly Data

per share eps CPI Adj_EPS
201403 -6.000 99.695 -7.789
201406 -2.000 100.560 -2.574
201409 -6.000 100.428 -7.732
201412 -7.000 99.070 -9.144
201503 -30.000 99.621 -38.973
201506 -6.000 100.684 -7.712
201509 -4.000 100.392 -5.157
201512 -10.000 99.792 -12.969
201603 -7.000 100.470 -9.017
201606 -9.000 101.688 -11.454
201609 -21.000 101.861 -26.682
201612 -8.000 101.863 -10.164
201703 -11.000 102.862 -13.840
201706 -9.800 103.349 -12.272
201709 -10.600 104.136 -13.174
201712 -4.400 104.011 -5.475
201803 -6.600 105.290 -8.113
201806 -5.200 106.317 -6.330
201809 -4.400 106.507 -5.347
201812 -3.600 105.998 -4.395
201903 -6.000 107.251 -7.240
201906 -4.400 108.070 -5.269
201909 -3.800 108.329 -4.540
201912 -5.200 108.420 -6.207
202003 -5.600 108.902 -6.655
202006 -3.400 108.767 -4.046
202009 -2.200 109.815 -2.593
202012 -2.200 109.897 -2.591
202103 -2.200 111.754 -2.548
202106 -2.400 114.631 -2.710
202109 -2.400 115.734 -2.684
202112 -3.000 117.630 -3.301
202203 -3.600 121.301 -3.841
202206 -3.400 125.017 -3.520
202209 -2.830 125.227 -2.925
202212 -2.400 125.222 -2.480
202303 -2.400 127.348 -2.439
202306 -2.400 128.729 -2.413
202309 -2.130 129.860 -2.123
202312 -2.030 129.419 -2.030

Add all the adjusted EPS together and divide 10 will get our e10.


Curis  (NAS:CRIS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Curis E10 Related Terms

Thank you for viewing the detailed overview of Curis's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Curis (CRIS) Business Description

Traded in Other Exchanges
Address
128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Executives
Jonathan B. Zung officer: CDO C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139
Anne Elizabeth Borgman director 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE MD 20705
John Hohneker director C/O DIMENSION THERAPEUTICS, INC., 840 MEMORIAL DRIVE 4TH FLOOR, CAMBRIDGE MA 02139
Marc Rubin director C/O TITAN PHARMACEUTICALS, INC., 400 OYSTER POINT BLVD., STE 505, SAN FRANCISCO CA 94080
Kenneth I Kaitin director C/O TUFTS CNTR FOR THE STUDY OF DRUG DEV, 75 KNEELAND ST, SUITE 1100, BOSTON MA 02111
Martyn D Greenacre director 41 MOORES ROAD, FRAZER PA 19355
Robert Martell officer: Head of Research & Development 4 MAGUIRE ROAD, LEXINGTON MA 02421
Diantha Duvall officer: CFO C/O GENOCEA BIOSCIENCES, INC., 100 ACORN PARK DRIVE 5TH FLOOR, CAMBRIDGE MA 02140
James E Dentzer director, officer: President & CEO C/O AMICUS THERAPEUTICS, INC., 6 CEDAR BROOK DRIVE, CRANBURY NJ 08512
William Steinkrauss officer: VP, Finance & Treasurer, other: Principal Accounting Officer C/O CURIS, INC.,, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Lori Anne Kunkel director C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Fattaey Ali Ph.d. officer: President & COO C/O CURIS, INC., 4 MAGUIRE ROAD, LEXINGTON MA 02421
James R Mcnab director C/O CURIS, INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Aurigene Discovery Technologies Ltd 10 percent owner 39-40 KIADB INDUSTRIAL AREA, PHASE II, ELECTRONIC CITY HOSUR ROAD, BANGALORE (KARNATAKA) K7 560100
David Tuck officer: Sr. Vice-President C/O CURIS, INC., 4 MAGUIRE ROAD, LEXINGTON MA 02421